The report lists Ethos Ltd as a momentum pick with a target price of ₹3,180, though detailed commentary is omitted from the excerpt provided.
Read this note →Research notes
What India's research desks published, reported with attribution and linked to the original notes. Orivam issues no recommendations of its own.
All houses
HDFC Securities
Motilal Oswal
Tata Asset Management
Mirae Asset Sharekhan
India IPO
Jainam
GEPL Capital
Way2Wealth
SBICAP Securities
Angel One
Axis Securities
ICICI Direct Research Retail
Religare
Arete Securities
Formerly known as Way2Wealth
ICICI Direct
Way2Wealth Securities
ICICI Securities
quant Mutual Fund
Kotak Securities
JM Financial
ICICI Securities – Retail
Global Markets by Vested
Ventura Securities
Prabhudas Lilladher
Industrial Asphalts
ITC Hotels
Exterminators PLC
Emkay Global
Private Client Group Research summarized from KIE research report
Kahawatte Plantations PLC
Elara Securities
10 notes from ICICI Securities · all time
The report assigns a BUY rating with a target price of ₹650 (38x FY28E EPS), citing paid music streaming penetration growth potential.
Read this note →The report lists Indian Hotels as a momentum pick with a target price of ₹990, though detailed commentary is omitted from the excerpt provided.
Read this note →The report recommends a BUY rating with a target of ₹2,765 (20x FY28E EBITDA), citing battery-materials capex and strategic tie-ups with Mitsubishi and Morita.
Read this note →The report lists Apollo Micro Systems as a pick with a target price of ₹485, citing a strong defence electronics order book and pipeline across indigenous programmes.
Read this note →The report recommends BUY with a target price of ₹2,210, citing upward revision of FY27 revenue/EBITDA guidance and accelerating capex.
Read this note →The report states a BUY rating with a SoTP-based target of ₹1,530, citing recruitment recovery, AI-led monetisation, and improving 99acres economics.
Read this note →The report assigns a BUY rating with a target of ₹1,480 (28x FY28E EPS), citing niche launches and the Rare and Orphan disease segment as growth drivers.
Read this note →The report recommends BUY with a target price of ₹540, citing margin recovery, resilient asset quality, and the new MD & CEO appointment effective January 2027.
Read this note →The report assigns a BUY rating on VPT with a target of ₹2,340 (30x FY28E P/E), citing diversification into data centers, semiconductors and nuclear power and a potential net-debt-free balance sheet in FY27E.
Read this note →